P3 Health Partners Inc. Common Stock
PIIIP3 Health Partners Inc. (PIII) is a healthcare company focused on value-based primary care. It operates a network of primary care clinics that aim to improve patient health outcomes through coordinated, personalized care models, often emphasizing preventative health and integration with specialty services. The company seeks to enhance healthcare quality while reducing costs for payers and patients.
Company News
Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims against P3 Health Partners, Inc. (PIII) for allegedly making false and misleading statements or omissions in violation of federal securities laws. The investigation is triggered by P3's disappointing financial results and a civil investigative demand from the Department of Justice.
Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of P3 Health Partners Inc. (PIII). Shareholders may be entitled to damages and corporate governance reforms.
P3 Health Partners is collaborating with healthcare providers in five states, providing assistance for compensation. See why PIII stock is a Buy.
P3 Health Partners (PIII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance. Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 mi...
